IDH1 and OCT4 in High Grade Astrocytoma
NCT06214689 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2024-08-06
Summary
observation of IDH1 and OCT4 markers level and high grade astrocytoma patients prognosis after excision.
Conditions
- High Grade Astrocytoma
Interventions
- OTHER
-
biomarkers analysis
IDH1 and OCT4 markers analysis of surgical specimens of high grade astrocytoma
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-30
- Primary Completion
- 2025-05-31
- Completion
- 2025-08-31
Countries
- Egypt
Study Locations
More Related Trials
-
Skull Base Reconstruction After Endonasal Cranio-endoscopic Resection Using Autologus Grafts
NCT03448614 ·Status: UNKNOWN
-
Immunophenotyping From Blood of Patients With Malignant Gliomas
NCT02022384 ·Status: COMPLETED
-
Validation Study of a Serum-miRNA Signature in Glioma Patients.
NCT06178692 ·Status: ACTIVE_NOT_RECRUITING
-
Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)
NCT01903967 ·Status: COMPLETED
-
Sphenoorbital Meningioma Management.
NCT04710485 ·Status: UNKNOWN
-
Biomarker-based Algorithm for Diagnosis of Glioma
NCT04194593 ·Status: UNKNOWN
-
Long-Term Outcomes of Hypopituitarism Following Gamma Knife Radiosurgery for Pituitary Adenomas
NCT07015645 ·Status: COMPLETED
-
Prediction of Sphenoid Septation in MRI Compared With CT and Intraoperative Findings During Endoscopic Pituitary Adenoma Surgery
NCT03624114 ·Status: COMPLETED
-
Non Invasive IDentification of Gliomas With IDH1 Mutation
NCT01703962 ·Status: COMPLETED
-
Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.
NCT03997136 ·Status: UNKNOWN
-
Surgical Management of Low Grade Glioma
NCT06499922 ·Status: NOT_YET_RECRUITING
-
Noninvasively Predicting Gene Status of Glioma
NCT03102112 ·Status: UNKNOWN
-
Non-invasive Glioma Characterization Through Molecular Imaging
NCT03684109 ·Status: RECRUITING ·Phase: NA
-
Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients
NCT05100173 ·Status: COMPLETED
-
Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
NCT06183983 ·Status: RECRUITING ·Phase: NA
-
Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
NCT02047058 ·Status: UNKNOWN
-
A Twenty-years' Experience in Pituitary Disease.
NCT06973824 ·Status: RECRUITING
-
Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
NCT06954636 ·Status: RECRUITING
-
Quality of Life and Patient Needs in Advanced High Grade Gliomas
NCT05039346 ·Status: COMPLETED
-
Methylation Patterns of the NUPR1, MGMT, NDRG2, and GLI1 Genes and Their Impact on Therapeutic Outcome of GBM Patients
NCT06538428 ·Status: COMPLETED
-
Glioma Patients Registry Based on Radiological, Histopathological and Genetic Analysis
NCT04220424 ·Status: UNKNOWN
-
Biomarkers for Prognosis of Glioblastoma (GBM)
NCT01493219 ·Status: COMPLETED
-
Comparative Study Between Different Approaches to CPA-petroclival Meningiomas
NCT03462914 ·Status: UNKNOWN
-
How the Precise Habitats Can Predict the IDH Mutation Status and Prognosis of the Patients With High-grade Gliomas
NCT04908267 ·Status: UNKNOWN
-
Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors
NCT06266949 ·Status: NOT_YET_RECRUITING